Literature DB >> 18990074

The role of NLRs and TLRs in the activation of the inflammasome.

Mihai G Netea1, Frank L van de Veerdonk, Bart Jan Kullberg, Jos W M Van der Meer, Leo A B Joosten.   

Abstract

BACKGROUND: Interleukin-1 beta is one of the most important pro-inflammatory cytokines. In contrast to other cytokines, activation of IL-1 beta requires processing from an inactive precursor by the cysteine protease caspase-1. Caspase-1 forms a protein platform called the inflammasome, together with proteins of the nucleotide-binding oligomerization domain-like receptor (NLR) family. OBJECTIVE/
METHODS: A review of literature investigating the stimulation of IL-1 beta production by microbial pathogens and their components. RESULTS/
CONCLUSIONS: To produce IL-1 beta, macrophages need a double stimulation with Toll like receptor (TLR) ligands that induce gene transcription, and NLR agonists (such as ATP or muramyl dipeptide (MDP)) that activate the inflammasome. Monocytes can release active IL-1 beta upon stimulation with TLR ligands alone. This probably represents an adaptation of each cell type to its environment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18990074     DOI: 10.1517/14712590802494212

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  24 in total

Review 1.  TLR4 polymorphisms and ageing: implications for the pathophysiology of age-related diseases.

Authors:  Carmela Rita Balistreri; Giuseppina Colonna-Romano; Domenico Lio; Giuseppina Candore; Calogero Caruso
Journal:  J Clin Immunol       Date:  2009-05-21       Impact factor: 8.317

2.  Caspase-8 promotes NLRP1/NLRP3 inflammasome activation and IL-1β production in acute glaucoma.

Authors:  Wei Chi; Fei Li; Hongrui Chen; Yandong Wang; Yingting Zhu; Xuejiao Yang; Jie Zhu; Frances Wu; Hong Ouyang; Jian Ge; Robert N Weinreb; Kang Zhang; Yehong Zhuo
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

3.  How can probiotics and prebiotics impact mucosal immunity?

Authors:  Sarah O'Flaherty; Delphine M Saulnier; Bruno Pot; James Versalovic
Journal:  Gut Microbes       Date:  2010-07-07

Review 4.  Chemokine receptor CXCR2: physiology regulator and neuroinflammation controller?

Authors:  Mike Veenstra; Richard M Ransohoff
Journal:  J Neuroimmunol       Date:  2012-03-22       Impact factor: 3.478

5.  Activation of the pyrin inflammasome by intracellular Burkholderia cenocepacia.

Authors:  Mikhail A Gavrilin; Dalia H A Abdelaziz; Mahmoud Mostafa; Basant A Abdulrahman; Jaykumar Grandhi; Anwari Akhter; Arwa Abu Khweek; Daniel F Aubert; Miguel A Valvano; Mark D Wewers; Amal O Amer
Journal:  J Immunol       Date:  2012-02-24       Impact factor: 5.422

Review 6.  Caspase functions in cell death and disease.

Authors:  David R McIlwain; Thorsten Berger; Tak W Mak
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-04-01       Impact factor: 10.005

Review 7.  Molecular and genetic inflammation networks in major human diseases.

Authors:  Yongzhong Zhao; Christian V Forst; Camil E Sayegh; I-Ming Wang; Xia Yang; Bin Zhang
Journal:  Mol Biosyst       Date:  2016-07-19

8.  Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors.

Authors:  Andrea Babelova; Kristin Moreth; Wasiliki Tsalastra-Greul; Jinyang Zeng-Brouwers; Oliver Eickelberg; Marian F Young; Peter Bruckner; Josef Pfeilschifter; Roland M Schaefer; Hermann-Josef Gröne; Liliana Schaefer
Journal:  J Biol Chem       Date:  2009-07-15       Impact factor: 5.157

9.  Functional and mechanistic integration of infection and the metabolic syndrome.

Authors:  Peter Sommer; Gary Sweeney
Journal:  Korean Diabetes J       Date:  2010-04-30

10.  Pyrin critical to macrophage IL-1beta response to Francisella challenge.

Authors:  Mikhail A Gavrilin; Srabani Mitra; Sudarshan Seshadri; Jyotsna Nateri; Freweine Berhe; Mark W Hall; Mark D Wewers
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.